Clinical trial Recruiting at 1 site Interventional Ages 2 to 17

Basilic versus cephalic vein approaches for pediatric midline catheter placement

Official title: Comparing Basilic and Cephalic Vein Approaches for Midline Catheter Placement in Children: A Randomized Controlled Trial

Run by Seoul National University Hospital · NCT07509359 · Data updated 2026-11-12

This trial will test whether using the basilic vein or the cephalic vein works better for placing a midline catheter in children aged 2–17 having general anesthesia.

Quick facts

Study typeInterventional
Ages2 Years to 17 Years
SexAll
Enrollment96 (estimated)
SponsorSeoul National University Hospital
Academic / other
Locations1 site (Seoul, Soul-t'ukpyolsi)
StatusRecruiting
StartedApril 1, 2026
Main results expectedApril 8, 2026
Study endsApril 1, 2030
Registry record updatedApril 3, 2026
Trial IDNCT07509359 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 2–17 undergoing general anesthesia who require midline catheter placement as judged by the attending anesthesiologist (for example, expected ≥2 postoperative blood draws, expected blood loss ≥40% estimated blood volume, continuous IV antibiotics, expected hospitalization ≥7 days, or surgical team request).

Probably not a fit

Children who need a central venous catheter, have coagulopathy, a history of severe thrombosis, or are otherwise excluded by investigators are unlikely to benefit from this comparison.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial will enroll 96 children aged 2–17 who need a midline catheter and will assign them 1:1 to catheter placement via the basilic or cephalic vein. The primary outcome is clinical blood sampling success during the catheter dwell period, defined as at least one aspiration of ≥2 mL of blood through the midline catheter without extra venipuncture. Secondary outcomes include operator-rated difficulty, number of puncture attempts, first-attempt cannulation success, vein diameter and depth, catheter dwell time, catheter-related complications, and patient satisfaction. The trial is single-center at Seoul National University Children's Hospital and procedures are performed under general anesthesia to standardize conditions.

Why it matters

Potential benefit: If successful, the preferred vein approach could increase reliable blood sampling through midline catheters and reduce additional needle sticks and related complications in hospitalized children.

How similar studies have gone: Some adult and device-focused studies have explored vein choice for catheter access with mixed results, but randomized data specifically comparing basilic versus cephalic approaches for pediatric midline placement are limited, making this comparison relatively novel in children.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 2-17 years undergoing general anesthesia
* Midline catheter placement deemed necessary by attending anesthesiologist (≥1 of: expected ≥2 postop blood draws; expected blood loss ≥40% EBV; continuous antibiotic therapy; hospitalization ≥7 days; surgical team request)

Exclusion Criteria:

* Need for central venous catheter per surgical team
* Coagulopathy
* History of severe thrombosis
* Other investigator-determined ineligibility

Where it's running

  • Hee-Soo Kim
    Seoul, Soul-t'ukpyolsi, South Korea
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.